1 – 20 of 53
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Cognitive Safety is Largely Ignored in Clinical Drug Trials : A Study of Registered Study Protocols
(
- Contribution to journal › Article
-
Mark
Pharmacotherapy for focal epilepsy : how close are we to a cure?
2024) In Expert Opinion on Pharmacotherapy(
- Contribution to journal › Debate/Note/Editorial
- 2021
-
Mark
Widespread skeptic attitudes among people with epilepsy toward generic antiseizure drugs – A Swedish survey study
(
- Contribution to journal › Article
-
Mark
Rash during lamotrigine treatment is not always drug hypersensitivity a retrospective cohort study among children and adults
(
- Contribution to journal › Article
- 2020
-
Mark
Allt fler kvinnor i fertil ålder tar antidepressiva läkemedel
(
- Contribution to journal › Article
- 2019
-
Mark
An evaluation of zonisamide, including its long-term efficacy, for the treatment of focal epilepsy
(
- Contribution to journal › Article
-
Mark
Quality of life after switching to generic levetiracetam – A prospective comparative study
(
- Contribution to journal › Article
-
Mark
Lamotrigine, bipolar disorder, and the pill-free week
(
- Contribution to journal › Debate/Note/Editorial
- 2018
-
Mark
Mechanisms Underlying Aggressive Behavior Induced by Antiepileptic Drugs : Focus on Topiramate, Levetiracetam, and Perampanel
(
- Contribution to journal › Scientific review
-
Mark
Skal gravide ha lavere eller høyere legemiddeldoser?
(
- Contribution to journal › Article
-
Mark
Zonisamide serum concentrations during pregnancy
(
- Contribution to journal › Article
-
Mark
Reference ranges for antiepileptic drugs revisited : A practical approach to establish national guidelines
(
- Contribution to journal › Article
-
Mark
Management of pregnant women with epilepsy who use lamotrigine
(
- Contribution to journal › Letter
- 2017
-
Mark
Impact of generic substitution on levetiracetam serum concentration - a prospective study in an outpatient setting
2017) 2017 American Epilepsy Society (AES) Annual Meeting(
- Contribution to conference › Abstract
-
Mark
Felles referanseområder for antiepileptika
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
No association between non-bullous skin reactions from lamotrigine and heterozygosity of UGT1A4 genetic variants *2(P24T) or *3(L48V) in Norwegian patients
(
- Contribution to journal › Article
-
Mark
Pharmacokinetic variability, efficacy and tolerability of eslicarbazepine acetate–A national approach to the evaluation of therapeutic drug monitoring data and clinical outcome
(
- Contribution to journal › Article
-
Mark
Hormone replacement therapy with estrogens may reduce lamotrigine serum concentrations : A matched case–control study
(
- Contribution to journal › Article
- 2016
-
Mark
The Impact of Pharmacokinetic Interactions with Eslicarbazepine Acetate Versus Oxcarbazepine and Carbamazepine in Clinical Practice
(
- Contribution to journal › Article
-
Mark
Treatment non-adherence in pseudo-refractory epilepsy
(
- Contribution to journal › Scientific review